openPR Logo
Press release

Intra-Uterine Contraceptive Devices Market Growing with the Highest CAGR by 2024

09-27-2017 02:22 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

"Global Intra-Uterine Contraceptive Devices Market" ? Industry Trends and Forecast to 2024

"Global Intra-Uterine Contraceptive Devices Market" ? Industry Trends and Forecast to 2024

Latest Research on “Global Intra-Uterine Contraceptive Devices Market” is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Intra-Uterine Contraceptive Devices Market Categories: Segmentation

Global Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD), End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

For a Free Sample Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

Table of Content:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
9. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES

Global Intra-Uterine Contraceptive Devices Market: Market Drivers

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

Increased Rate of Unplanned Pregnancies:

Adolescents most commonly use contraceptive methods with relatively high typical use failure rates such as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent use, and use of methods with high typical use failure rates are reflected in the high rate of unintended adolescent pregnancies in the U.S.

Rising Number of Initiatives Undertaken By the Private Firms:

The increasing number of initiatives taken by the U.S. government has helped to limit the rising number of unplanned pregnancies and abortions rate in the U.S. In addition, many U.S.-based private firms also contribute towards the solutions for pregnancy-related issues, which include maternal mortality, teenage pregnancies, growing number of abortions, and so on, by promoting the use of contraceptives, such as intrauterine contraceptive devices.

Favourable Insurance for IUCD’s:

The insurance policy is propelling the IUCD market towards growth. In Finland, national insurance covers acute but not preventive care, and contraceptives are usually paid by the patient. In Sweden, the copper IUCDs are available free of cost, whereas hormonal IUCDs are not. All FDA-approved contraceptives in the U.S. are covered by insurance.

Growing Awareness of Contraceptive:

The need to avoid unwanted pregnancies, especially among teenagers, is one of the major drivers for this market. It has also been observed that for over half of the users also identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain and acne, as reasons for use. This is also one of the factors contributing to the growth of the market in Europe.

Speak to Analyst Visit @http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-intra-uterine-contraceptive-devices-market

Some of the major players operating in this market are:

• Bayer AG
• Teva Pharmaceuticals Industries Ltd.
• Mona Lisa N.V.
• DKT International
• Egemen International
• Melbea AG, Ocon Medical Ltd.
• Pregna International Limited
• Medical Engineering Corporation SA
• SMB Corporation and Meril Life Sciences Pvt. Ltd.
• Medu Scientific Ltd
• China RH Contraceptives Co., Ltd
• Sanghai Jolly Medical Education Co., Ltd
• Bernstein Leibhard LLP
• ZheijangDaji Medical Instruments, Ltd.
• Nimble International
• AME Line
• Technico
• Cepeo
• Contraceptivos
• InjeflexInd
• Com Ltd
• Bersil

The Global Intra-Uterine Contraceptive Devices Market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Bayer AG dominated the IUCD devices market accounting for a highest market share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed among others holds 34.0% of the IUCDdelivery market in 2016.

BAYER HEALTHCARE AG

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science. The HealthCare segment offers a wide range of products under animal health, pharmaceuticals, consumer care, and medical care. The pharmaceutical business offers a wide range of products in the therapeutic area of oncology, haematology, and ophthalmology, and offers products for women’s health and cardiology therapeutic applications.

Recent Developments:

In October 2016, Bayer AG has successfully concluded the European registration procedure to gain EUwide marketing authorization for its new low-dose levonorgestrel-releasing intrauterine system (LNGIUS). The product is named Kyleena and will be available in the market from 2017 January.

In September 2016, Bayer AG has successfully received FDA approval for its new low-dose levonorgestrel releasing intrauterine system (LNG-IUS) “Kyleena” The launch of this product in October in U.S.

Read more about the Global Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

Related Report

Global Prosthetic Heart Valve Market – Trends and Forecast to 2024

Global Prosthetic Heart Valve Market, By Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)– Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-prosthetic-heart-valve-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intra-Uterine Contraceptive Devices Market Growing with the Highest CAGR by 2024 here

News-ID: 743763 • Views: 124

More Releases from Data Bridge Market Research

Radiotherapy Market is Booming Worldwide With CIVCO Medical Solutions, Brainlab …
Global Radiotherapy Market is expected to reach at a CAGR of 7.7% in the forecast period of 2018 to 2025. Global Radiotherapy Market, By Therapy (Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Softwares, Systemic Radiotherapy), By Application (Prostrate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) –
Cable Assembly Market Quantitative Analysis By TE Connectivity, Molex, LLC, W. L …
The cable assembly report aids in achieving an extreme sense of evolving industry movements before the competitors. This market research report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. It becomes easy to analyse the actions of key players and its effect on the sales, import, export, revenue and CAGR values with this cable assembly report. The report is also a helpful source of assistance
Aroma Chemicals Market 2019:Quantitative Analysis By Hindustan Mint & Agro Produ …
The market analysis of aroma chemicals market report provides an examination of various market segments that are supposed to witness the fastest development amid the estimated forecast frame. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The best tools have been adopted to generate this report which is SWOT
Industrial Communication Market 2019:Industry Analysis By OMRON Corporation, Sch …
Global industrial communication market is set to witness a healthy CAGR of 11.12% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing adoption of industrial internet of things and increasing demand for wireless networks are the factor for the growth of this market. Industrial communication report is a well-generated market report which helps achieve comprehensive analysis of the market

All 5 Releases


More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Asia-Pacific Contraceptive Drugs Market Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Sample Copy
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the